Tokyo Tape
Sign in
← Solasia Pharma

Quarterly report · Q1

4597.TEDINET S100TG1L
Period2024-01-01 → 2024-03-31
Filed2024-05-15
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥11m2024-01-01 → 2024-03-31Cons.Revenue IFRS
Revenue¥617m2023-01-01 → 2023-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥220m2023-01-01 → 2023-03-31Cons.Revenue IFRS
Operating income−¥307m2024-01-01 → 2024-03-31Cons.Operating profit loss IFRS
Operating income−¥245m2023-01-01 → 2023-03-31Cons.Operating profit loss IFRS
Profit before tax−¥318m2024-01-01 → 2024-03-31Cons.Profit loss before tax IFRS
Profit before tax−¥1.1bn2023-01-01 → 2023-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax−¥247m2023-01-01 → 2023-03-31Cons.Profit loss before tax IFRS
Net income (owners)−¥310m2024-01-01 → 2024-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥1.1bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)−¥241m2023-01-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income−¥310m2024-01-01 → 2024-03-31Cons.Profit loss IFRS
Net income−¥241m2023-01-01 → 2023-03-31Cons.Profit loss IFRS
Total assets¥2.7bnat 2024-03-31Cons.Assets IFRS
Total assets¥2.2bnat 2023-12-31Cons.Assets IFRS
Total assets¥3.0bnat 2023-03-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥884mat 2024-03-31Cons.Liabilities IFRS
Total liabilities¥354mat 2023-12-31Cons.Liabilities IFRS
Net assets / equity¥1.8bnat 2024-03-31Cons.Equity IFRS
Net assets / equity¥1.9bnat 2023-12-31Cons.Equity IFRS
Net assets / equity¥2.4bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥2.7bnat 2022-12-31dCons.Equity IFRS
Equity (owners)¥1.8bnat 2024-03-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥1.9bnat 2023-12-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥2.4bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥1.3bnat 2024-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥728mat 2023-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥1.0bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥803mat 2022-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow−¥164m2024-01-01 → 2024-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow−¥359m2023-01-01 → 2023-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥223m2023-01-01 → 2023-03-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow¥02023-01-01 → 2023-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow¥02023-01-01 → 2023-03-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥743m2024-01-01 → 2024-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥275m2023-01-01 → 2023-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥12m2023-01-01 → 2023-03-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥-1.782024-01-01 → 2024-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥-6.622023-01-01 → 2023-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥-1.442023-01-01 → 2023-03-31Cons.Basic earnings loss per share IFRS
EPS (diluted)¥-1.782024-01-01 → 2024-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-6.622023-01-01 → 2023-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥-1.442023-01-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS
Equity ratio67.3%at 2024-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio84.1%at 2023-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio81.1%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 444
ItemContextValueUnit
Deferred tax liabilities IFRSPrior1YearInstant22000000JPY
Deferred tax liabilities IFRSCurrentQuarterInstant13000000JPY
Lease liabilities ncl IFRSPrior1YearInstant27000000JPY
Lease liabilities ncl IFRSCurrentQuarterInstant20000000JPY
Other non current liabilities ncl IFRSPrior1YearInstant10000000JPY
Other non current liabilities ncl IFRSCurrentQuarterInstant14000000JPY
Non current labilities IFRSPrior1YearInstant61000000JPY
Non current labilities IFRSCurrentQuarterInstant47000000JPY
Liabilities IFRSPrior1YearInstant354000000JPY
Liabilities IFRSCurrentQuarterInstant884000000JPY
Share capital IFRSPrior1YearInstant1596000000JPY
Share capital IFRSCurrentQuarterInstant1726000000JPY
Capital surplus IFRSPrior1YearInstant1657000000JPY
Capital surplus IFRSCurrentQuarterInstant1774000000JPY
Retained earnings IFRSPrior1YearInstant-1336000000JPY
Retained earnings IFRSCurrentQuarterInstant-1646000000JPY
Treasury shares IFRSPrior1YearInstant-69000000JPY
Treasury shares IFRSCurrentQuarterInstant-66000000JPY
Other components of equity IFRSPrior1YearInstant26000000JPY
Other components of equity IFRSCurrentQuarterInstant35000000JPY
Equity IFRSPrior1YearInstant1875000000JPY
Equity IFRSCurrentQuarterInstant1823000000JPY
Liabilities and equity IFRSPrior1YearInstant2229000000JPY
Liabilities and equity IFRSCurrentQuarterInstant2708000000JPY
Revenue IFRSPrior1YTDDuration220000000JPY
Revenue IFRSCurrentYTDDuration11000000JPY
Cost of sales IFRSPrior1YTDDuration91000000JPY
Cost of sales IFRSCurrentYTDDuration11000000JPY
Gross profit IFRSPrior1YTDDuration128000000JPY
Gross profit IFRSCurrentYTDDuration0JPY
Research and development expenditure recognized as expense during period IFRSPrior1YTDDuration93000000JPY
Research and development expenditure recognized as expense during period IFRSCurrentYTDDuration76000000JPY
Selling general and administrative expenses IFRSPrior1YTDDuration280000000JPY
Selling general and administrative expenses IFRSCurrentYTDDuration232000000JPY
Operating profit loss IFRSPrior1YTDDuration-245000000JPY
Operating profit loss IFRSCurrentYTDDuration-307000000JPY
Finance income IFRSPrior1YTDDuration0JPY
Finance income IFRSCurrentYTDDuration0JPY
Finance costs IFRSPrior1YTDDuration0JPY
Finance costs IFRSCurrentYTDDuration10000000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1YTDDuration-1000000JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentYTDDuration-0JPY
Profit loss before tax IFRSPrior1YTDDuration-247000000JPY
Profit loss before tax IFRSCurrentYTDDuration-318000000JPY
Income tax expense IFRSPrior1YTDDuration-6000000JPY
Income tax expense IFRSCurrentYTDDuration-8000000JPY
Profit loss IFRSPrior1YTDDuration-241000000JPY
Profit loss IFRSCurrentYTDDuration-310000000JPY
Profit loss attributable to owners of parent IFRSPrior1YTDDuration-241000000JPY
Profit loss attributable to owners of parent IFRSCurrentYTDDuration-310000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-12-31pass
balance sheet identityconsolidated 2024-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-03-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-03-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-03-31pass
statement vs summary · revenueconsolidated 2024-01-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsconsolidated 2024-03-31pass